Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases

Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2017;65(1):310-335.

Publication Type:

Journal Article

Authors:

Garcia-Tsao, G; Abraldes, JG; Berzigotti, A; Bosch, J

Source:

Hepatology, Volume 65, Issue 1, p.310-335 (2017)

Cited On:

Monitoring Patients Who Are Starting HCV Treatment, Are on Treatment, or Have Completed Therapy

Export Citation:

RIS Format

Top